Parliamentary Search

Written question asked by Allison Gardner (Labour) on Monday, 2 March 2026, in the House of Commons. It was due for an answer on Wednesday, 4 March 2026. It was answered by Zubir Ahmed (Labour) on Tuesday, 10 March 2026 on behalf of the Department of Health and Social Care.

Urinary Tract Infections: Vaccination

Question

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research on vaccinations against recurrent and chronic urinary tract infections.

Answer

The Department funds research through the National Institute for Health and Care Research (NIHR). The NIHR funds, supports, and carries out high-quality research to improve health outcomes and care services. Over the last five financial years, the Department has provided over £22 million in programme research funding for urinary tract infection (UTI) research, including research on improved treatment for recurrent and chronic UTIs. In addition, NIHR infrastructure is supporting Phase 3 trials on vaccines against Escherichia coli infection in older adults who have a history of UTI, delivered by the NIHR Bristol Clinical Research Facility and the NIHR Wellcome Trust Manchester Clinical Research Facility.

The NIHR also funds the James Lind Alliance, which has run a Priority Setting Partnership (PSP) focused on chronic and recurrent UTIs. This PSP, funded by AMR Action UK and delivered in partnership with Bladder Health UK and The Urology Foundation, has identified the top 10 research priorities in this area. A rolling funding opportunity is available for research projects that align with priorities aligning with PSPs.

Secondary information

Type
Written question
Reference
117207
Session
2024-26
Subjects
Research Vaccination Urinary tract infections
Link
View this Written question on www.parliament.uk